Sangamo enters asset purchase agreement with PTC Therapeutics
Sangamo Therapeutics (SNGM) has entered into an asset purchase agreement dated August 25, 2026, with PTC Therapeutics. The agreement details the terms for the sale and purchase of specified assets, with closing conditions including the delivery of closing deliverables.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day